Peptide record

TPDB23198

Antibacterial Antiviral Toxicity standard
13 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB23198
Antibacterial Antiviral Toxicity
Anti-infective peptides Toxicity and safety peptides
Peptipedia AI4AVP dbAMP 3.0 DRAVP 2.0
standard
No
A 13-aa standard natural multi-activity (Antibacterial, Antiviral, and Toxicity) peptide sequence curated from Peptipedia, AI4AVP, dbAMP 3.0, and other sources, with an available 3D structural model.
Sequence
LWGHIWNFVHGLI
Physicochemical Analysis
C80H110N20O15
ARDCEQKMPSTY
GHILW
1591.88
8.00
2
0
8
+0
-4.14
0.854
142.31
Mammalian: 5.5 hour Yeast: 3 min E.coli: 2 min
11000
691.01
1
Residue Composition
number
0
A
0
R
1
N
0
D
0
C
0
E
0
Q
2
G
2
H
2
I
2
L
0
K
0
M
1
F
0
P
0
S
0
T
2
W
0
Y
1
V
Amino Acid Distribution
A: 0 R: 0 N: 1 D: 0 C: 0 E: 0 Q: 0 G: 2 H: 2 I: 2 L: 2 K: 0 M: 0 F: 1 P: 0 S: 0 T: 0 W: 2 Y: 0 V: 1
Chemical Descriptors
13
C80H110N20O15
1591.88
8.00
+0
-4.14
0.854
Evidence Records 3 records
Evidence 1 Activity

Activity

50% Cytotoxicity
Toxicity
27.60 µg/mL
Cytotoxic
50% Cytotoxicity | 27.60 | µg/mL | target cell: Vero cells

Target

Vero cells

Source & Reference

NA
DBAASP
Histidine-rich Modification of a Scorpion-derived Peptide Improves Bioavailability and Inhibitory Activity against HSV-1. | Theranostics | 2018
Evidence 2 Activity

Activity

Toxicity
Cytotoxic
Cytotoxicity: [Ref.29290802]Vero cell:CC50=27.60 µg/mL.

Source & Reference

NA
DRAMP
Theranostics. 2018 Jan 1 8(1):199-211.
Evidence 3 Activity

Activity

Toxicity
Cytotoxic
Cytotoxicity: [Ref.29290802]Vero cells: CC50 = 27.60 µg/mL.

Source & Reference

NA
DRAMP
Theranostics. 2018 Jan 1 8(1):199-211.